Follow Therapeutics on Index.co

More info

Parent markets

Sibling markets

Related markets

300+ companies in Therapeutics
Show all

Amgen Inc.

Manufacturing +2

Seattle Genetics

Health Care +2

Takeda

Pharmaceuticals +1

Aimmune

Health and Wellness +2

Moderna Therapeutics

Biotechnology +1

Cerevel Therapeutics

Biotechnology +1

Cyteir

Biotechnology +1

Nohla Therapeutics

Biotechnology +2

Neuronetics, Inc.

Biotechnology +2

Kaia Health

Artificial Intelligence +2

Puma Biotechnology

Biotechnology +1

Scholar Rock

Medical +2

Pine Biotech

Big Data +3

Beam Therapeutics

Health Care +1

NeuEve

E-Commerce +3

All companies in Therapeutics

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Filter companies

21 Feb 2019

$300,000,000 From

Seattle biotech Immune Design acquired by drug giant Merck for $300M

GeekWire

24 Jul 2018

Acquired by

Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition

Xconomy

09 Jan 2017

Acquired by

Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds

prnewswire

11 Nov 2016

$78,000,000 From

Eagle Pharmaceuticals to acquire Arsia Therapeutics for $30M

NJBIZ

27 Oct 2016

$200,000,000 From

Allergan to Acquire Motus Therapeutics Genetic Engineering & Biotechnology News - Biotech from Bench to Business

GEN

02 Sep 2016

Acquired by

Together into the future: Hocoma merges with DIH International to provide total solution for modern rehabilitation.

hocoma

01 Aug 2016

$150,000,000 From

Pfizer Continues Gene Therapy Push With $150M Bamboo Buyout

Xconomy

10 May 2016

Acquired by

24 Mar 2016

Acquired by

24 Nov 2014

$840,000,000 From

17 Jun 2013

$223,000,000 From

10 Apr 2012

$315,000,000 From

Index

By TNW

Therapeutics

Amgen Inc.

Seattle Genetics

Takeda

Aimmune

Moderna Therapeutics

Cerevel Therapeutics

Cyteir

Nohla Therapeutics

Neuronetics, Inc.

Kaia Health

Puma Biotechnology

Scholar Rock

Pine Biotech

Beam Therapeutics

NeuEve

News

Funding rounds

Acquisitions

Companies

Investors

Seattle biotech Immune Design acquired by drug giant Merck for $300M

Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition

Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds

Eagle Pharmaceuticals to acquire Arsia Therapeutics for $30M

Allergan to Acquire Motus Therapeutics Genetic Engineering & Biotechnology News - Biotech from Bench to Business

Together into the future: Hocoma merges with DIH International to provide total solution for modern rehabilitation.

Pfizer Continues Gene Therapy Push With $150M Bamboo Buyout